Skip to content
value.today

Evofem Holdings, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2015
Total raised
$48 M
3 rounds on record
Latest round
$8 M
Jul 2017
First round on record
Nov 2015
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Evofem Holdings, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2017$8 MNo. 3$2 to $10 million

Evofem Holdings, Inc.: Raise no. 3, Jul 2017

Investors in this round

2 investors had bought by the notice of Aug 9, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $10 M offered; $3 M still to sell
Smallest investment taken
$2,500,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ellen Thomas · Executive Officer
  • Jay File · Executive Officer
  • Kelly Culwell · Executive Officer
  • Saundra Pelletier · Executive Officer, Director
  • Colin Rutherford · Director
  • Natalie Douglas · Director
  • Simon Best · Director
  • Thomas Darden II · Director
  • Thomas Lynch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jay File, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 9, 2017. Read the notice at the SEC.

equitySEC
Jul 2016$21 MNo. 2$10 to $50 million

Evofem Holdings, Inc.: Raise no. 2, Jul 2016

Investors in this round

2 investors had bought by the notice of Aug 2, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $30 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ellen F. Thomas · Executive Officer · Secretary
  • Jay F. File · Executive Officer · Chief Financial Officer
  • Kelly F. Culwell · Executive Officer · Chief Medical Officer
  • Saundra Pelletier · Executive Officer, Director · Chief Executive Offcier
  • Colin F. Rutherford · Director
  • Natalie F. Douglas · Director
  • Simon F. Best · Director
  • Thomas F. Darden II · Director
  • Thomas F. Lynch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jay File, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 2, 2016. Read the notice at the SEC.

equitySEC
Nov 2015$20 MNo. 1$10 to $50 million

Evofem Holdings, Inc.: Raise no. 1, Nov 2015

Investors in this round

7 investors had bought by the notice of Dec 2, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jay F. File · Executive Officer · Chief Financial Officer
  • John F. Fair · Executive Officer · COO
  • Kelly F. Culwell · Executive Officer · Chief Medical Officer
  • Saundra Pelletier · Executive Officer, Director · CEO
  • Colin F. Rutherford · Director
  • Natalie F. Douglas · Director
  • Simon F. Best · Director
  • Thomas F. Darden II · Director
  • Thomas F. Lynch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Saundra Pelletier, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 2, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Evofem Holdings, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2017).

    SEC Form D · Aug 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2017

That is all the official record says: Evofem Holdings, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Evofem Holdings, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Evofem Holdings, Inc.
NameRoleNamed in
Ellen ThomasExecutive officerAug 2017
Jay FileExecutive officerAug 2017
Kelly CulwellExecutive officerAug 2017
Saundra PelletierExecutive officerAug 2017
Ellen F. ThomasSecretaryAug 2016
Jay F. FileChief Financial OfficerAug 2016
Kelly F. CulwellChief Medical OfficerAug 2016
John F. FairCOODec 2015
Colin RutherfordDirectorAug 2017
Natalie DouglasDirectorAug 2017
Saundra PelletierDirectorAug 2017
Simon BestDirectorAug 2017
Thomas Darden IIDirectorAug 2017
Thomas LynchDirectorAug 2017
Colin F. RutherfordDirectorAug 2016
Natalie F. DouglasDirectorAug 2016
Simon F. BestDirectorAug 2016
Thomas F. Darden IIDirectorAug 2016
Thomas F. LynchDirectorAug 2016